Even in unprecedented times, the price you pay still matters
In these unprecedented times, an enduring lesson for investors is that the price you pay matters most in the end.
The unprecedented impact of COVID-19 across business and society is invoking a fiscal response last used by wartime governments 75 years ago.
In this article we explain how developed economies are deploying World War 2 levels of fiscal stimulus. We also discuss portfolio positioning for current conditions and why it’s the price you pay that matters most in the end.
Waging war on a financial virus
When Rishi Sunak, UK Chancellor of the Exchequer, unveiled Britain’s enormous 350-billion-pound stimulus package, he asserted: “We have never in peacetime faced an economic fight like this one.”
This sentiment is captured perfectly in the chart below, which shows that governments are positioning themselves to unleash wartime responses at the fiscal level in response to COVID-19.
We’re getting very close to those World War 2 levels. If 25% is that magic number, you can see that the UK has already announced measures there are ~17% of GDP plus a few percent from their deficit to start with. With the contraction of GDP that you could expect given what we’re going through, we’re starting to get to numbers in the 20-25% range over the next month or two.
The question is whether even this level of stimulus would be enough to support the sheer number of workers, businesses and other entities thrown into turmoil due to the global pandemic. The key to that of course is how long it takes governments to bring COVID-19 under control, with cases continuing to skyrocket around the world and the U.S. disturbingly surpassing China as the country with the most infections.
There are some economists forecasting U.S. GDP to contract 25-30% this quarter. That’s a rate of decline that we’ve never seen before and we’re not expecting a V-shaped recovery. There’ll be quite a lot of dislocations in investment markets because of the shock we’re going through.
It's the price you pay that matters
A key lesson for investors is pay a high price, expect a lower future return. It’s probably the most important lesson investors can take away from a bear market that’s brought a swathe of high PE stocks to their knees.
The 40-70% share price falls across hyped up IT-stocks over the past month are reminiscent of Computershare (ASX:CPU) was Australia’s posterchild of the early 2000s tech bubble. Even though Computershare was growing earnings, its stock price flew past business fundamentals and then crashed back down to earth.
Consequently, as the chart below shows, for those investors who bought at the top, the convergence between earnings reality and valuations meant 15 years of no capital growth.
Even with earnings per share growing at 11% CAGR, this example shows you the only thing that matters as an investor is the starting multiple. It’s a note of caution that we now add for investors paying greater than 30-40 times P/E. It’s very difficult for investors to generate superior returns in the long-run when they pay high prices.
This could be a portent of things to come for some of the expensive stocks shown below.
Where are ASX 300 valuations now?
Taking a step back to consider the broader market, cyclically adjusted P/Es are approaching levels last seen during the global financial crisis (see chart below).
While you’d think that this would whet buyers’ appetites, there is a big caveat for those in search of value: significant downside risk remains.
There’s a lot priced in already albeit earnings haven’t rebased yet, so even on a 10-year average there will be a material upwards revision to multiples. Obviously significant earnings declines will come through in August FY 20 earnings, but the knock on into FY 21 could be material as well depending on the extent of the dislocation in the labour force and how that will knock on through into consumption and activity.
The key to investing in Australian equities in the current environment is to consider where valuations are, and where earnings will be through the cycle. While there have been sharp market falls across almost all sectors, this could present opportunities to buy businesses at more attractive prices.
Here are some examples of how we are positioning our Australian equity portfolios:
- Favouring resource stocks, and industrial and consumer staple stocks with defensive revenue and earnings streams that are well-placed to weather the volatility.
The majority of resources businesses have exceptionally strong balance sheets and proven capability in dealing with fluctuating price cycles and volatile revenue streams. To date, the effect on iron ore pricing has been mild. While prices for some commodities, such as alumina, aluminium and copper are more depressed, nearly all are still in relatively strong financial positions. We believe most resource stocks are now attractively priced and offer strong long-term return prospects.
- Selectively adding risk in businesses where valuations have become more attractive and can be expected to rebound strongly post short-term challenges.
Unsurprisingly, airline, tourism, casino and gaming stocks have been amongst the hardest hit by COVID-19. Given capacity reductions, high fixed costs and minimal short-term revenue, solvency issues will be significant for these industries. At the other end of the spectrum, supermarkets are experiencing an increase in earnings – however we feel this is transitory and should not materially impact valuation.
- Cautious on bank positioning given the likelihood of increasing bad debts and the limited ability of monetary policy to provide support.
The good news is that all Australian banks have materially boosted their capital levels since the GFC and are among the best capitalised banks in the world. Bank stocks with the exception of CBA are currently very cheap. However, for now we remain cautious on the sector due to its sensitivity to bad debts, high correlation to economic risks and high absolute weight in the equity market.
We are also adding smaller positions in energy stocks where valuations have been savaged, albeit cautiously. On the flip side, an area they are continuing to avoid is healthcare where “already aggressive valuations have become even more aggressive relative to an overall equity market level which is materially lower.
This article was originally produced by the team at Livewire.
This document is issued by Schroder Investment Management Australia Limited (ABN 22 000 443 274, AFSL 226473) (Schroders). It is intended solely for wholesale clients (as defined under the Corporations Act 2001 (Cth)) and is not suitable for distribution to retail clients. This document does not contain and should not be taken as containing any financial product advice or financial product recommendations. This document does not take into consideration any recipient’s objectives, financial situation or needs. Before making any decision relating to a Schroders fund, you should obtain and read a copy of the product disclosure statement available at www.schroders.com.au or other relevant disclosure document for that fund and consider the appropriateness of the fund to your objectives, financial situation and needs. You should also refer to the target market determination for the fund at www.schroders.com.au. All investments carry risk, and the repayment of capital and performance in any of the funds named in this document are not guaranteed by Schroders or any company in the Schroders Group. The material contained in this document is not intended to provide, and should not be relied on for accounting, legal or tax advice. Schroders does not give any warranty as to the accuracy, reliability or completeness of information which is contained in this document. To the maximum extent permitted by law, Schroders, every company in the Schroders plc group, and their respective directors, officers, employees, consultants and agents exclude all liability (however arising) for any direct or indirect loss or damage that may be suffered by the recipient or any other person in connection with this document. Opinions, estimates and projections contained in this document reflect the opinions of the authors as at the date of this document and are subject to change without notice. “Forward-looking” information, such as forecasts or projections, are not guarantees of any future performance and there is no assurance that any forecast or projection will be realised. Past performance is not a reliable indicator of future performance. All references to securities, sectors, regions and/or countries are made for illustrative purposes only and are not to be construed as recommendations to buy, sell or hold. Telephone calls and other electronic communications with Schroders representatives may be recorded.